These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15239978)

  • 1. Reliable high-throughput functional screening with 3-FABS.
    Dalvit C; Ardini E; Fogliatto GP; Mongelli N; Veronesi M
    Drug Discov Today; 2004 Jul; 9(14):595-602. PubMed ID: 15239978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity improvement in 19F NMR-based screening experiments: theoretical considerations and experimental applications.
    Dalvit C; Mongelli N; Papeo G; Giordano P; Veronesi M; Moskau D; Kümmerle R
    J Am Chem Soc; 2005 Sep; 127(38):13380-5. PubMed ID: 16173772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A general NMR method for rapid, efficient, and reliable biochemical screening.
    Dalvit C; Ardini E; Flocco M; Fogliatto GP; Mongelli N; Veronesi M
    J Am Chem Soc; 2003 Nov; 125(47):14620-5. PubMed ID: 14624613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
    Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening of enzyme inhibition using an inhibitor gradient generated in a microchannel.
    Garcia E; Hasenbank MS; Finlayson B; Yager P
    Lab Chip; 2007 Feb; 7(2):249-55. PubMed ID: 17268628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of fragment-based n-FABS NMR screening applied to the membrane enzyme FAAH.
    Lambruschini C; Veronesi M; Romeo E; Garau G; Bandiera T; Piomelli D; Scarpelli R; Dalvit C
    Chembiochem; 2013 Sep; 14(13):1611-9. PubMed ID: 23918626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a new drug--from target identification to ultra-high-throughput screening.
    Golz S; Hüser J
    Clin Lab; 2007; 53(1-2):77-9. PubMed ID: 17323829
    [No Abstract]   [Full Text] [Related]  

  • 8. An efficient method for the detection and elimination of systematic error in high-throughput screening.
    Makarenkov V; Zentilli P; Kevorkov D; Gagarin A; Malo N; Nadon R
    Bioinformatics; 2007 Jul; 23(13):1648-57. PubMed ID: 17463024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyfluorinated amino acids for sensitive 19F NMR-based screening and kinetic measurements.
    Papeo G; Giordano P; Brasca MG; Buzzo F; Caronni D; Ciprandi F; Mongelli N; Veronesi M; Vulpetti A; Dalvit C
    J Am Chem Soc; 2007 May; 129(17):5665-72. PubMed ID: 17417847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM; Schurdak ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTS technologies in biopharmaceutical discovery.
    Wu G; Doberstein SK
    Drug Discov Today; 2006 Aug; 11(15-16):718-24. PubMed ID: 16846799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of high-content analysis for compound screening and target selection.
    Rausch O
    IDrugs; 2005 Jul; 8(7):573-7. PubMed ID: 15973566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening technologies for drug glucuronidation profiling.
    Trubetskoy O; Finel M; Trubetskoy V
    J Pharm Pharmacol; 2008 Aug; 60(8):1061-7. PubMed ID: 18644198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening systems.
    Reymond JL; Babiak P
    Adv Biochem Eng Biotechnol; 2007; 105():31-58. PubMed ID: 17408081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment-based activity space: smaller is better.
    Hesterkamp T; Whittaker M
    Curr Opin Chem Biol; 2008 Jun; 12(3):260-8. PubMed ID: 18316043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using NMR for ligand discovery and optimization.
    Villar HO; Yan J; Hansen MR
    Curr Opin Chem Biol; 2004 Aug; 8(4):387-91. PubMed ID: 15288248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [NMR-based screening of protein inhibitors in drug discovery].
    Hu HY
    Yao Xue Xue Bao; 2002 Feb; 37(2):158-60. PubMed ID: 12579966
    [No Abstract]   [Full Text] [Related]  

  • 20. NMR methods in fragment screening: theory and a comparison with other biophysical techniques.
    Dalvit C
    Drug Discov Today; 2009 Nov; 14(21-22):1051-7. PubMed ID: 19716431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.